VTI Chief Medical Officer Ashley Tuan OD, PhD, tells how the 2nd year (of 3) of our clinical trial proves NaturalVue Multifocal corrects astigmatism while managing myopia and presbyopia in real life conditions. Rm. 207 October 10th, 8 AM at #Academy25.
VTI Chief Medical Officer Ashley Tuan OD, PhD, tells how the 2nd year (of 3) of our clinical trial proves NaturalVue Multifocal corrects astigmatism while managing myopia and presbyopia in real life conditions. Rm. 207 October 10th, 8 AM at #Academy25.
A lens boosted patient loyalty 30%: Josie Ziegler, OD found NaturalVue’s Multifocal lenses to be ‘nothing short of amazing’ for her practice. They correct astigmatism, manage myopia/presbyopia and offer a high level of comfort. Article at https://t.co/K3cT2izfrT MKT-AST-SM1 r1
VTI Chief Medical Officer Ashley Tuan says we no longer have to choose between correcting astigmatism and managing myopia. A clinical study of NaturalVue Multifocal demonstrates proven astigmatism correction of 100% up to 3.00 D. See the article at:
https://t.co/BvmlDJkcN9
Finally, more support that myopia is a disease and should be treated as such. Check out the new report from The National Academies of Sciences, Engineering, and Medicine entitled Myopia: Causes, Prevention, and Treatment of an Increasingly Common Disease.
If you have any myopic teenage patients on the road for the first time, consider fitting them in NaturalVue® Enhanced Multifocal 1 Day Contact Lenses. Our lenses offer an extended depth of focus and good peripheral vision. Learn more: https://t.co/Y2uhiEYMid
#VTI
MKT-VTI-SM54 r5
Are you ready for back-to-school eye exams?
Ask your patients if they have trouble reading the white board in the classroom—it might an early sign of myopia. Start early intervention with NaturalVue® Enhanced Multifocal 1 Day Contact Lenses:https://t.co/Y2uhiEYMid
MKT-VTI-SM54 r5
Did you know that NaturalVue® Enhanced Multifocal 1 Day Contact Lenses may be effective for myopic patients with astigmatism? Read how eyecare practitioners are using our lenses to treat their astigmatic patients in RMM's recent article: https://t.co/IDnWPYKrcU
MKT-VTI-SM54 r5
NaturalVue® Enhanced Multifocal 1 Day Contact Lenses have shown to be effective for myopic patients with astigmatism. Read how eyecare practitioners are using our lenses to treat their astigmatic patients in a recent article: https://t.co/7kHbT7qPFl
MKT-VTI-SM54 r4.1
Remind your patients that vision needs go beyond the classroom. From reading sheet music, to driving safely, clear vision is crucial. Learn how NaturalVue® Enhanced Multifocal 1 Day Contact Lenses deliver excellent vision at all distances:https://t.co/Y2uhiEYMid MKT-VTI-SM54 r4.1
With back-to-school eye exams on the horizon, it's essential to recognize that vision needs extend beyond the classroom. Learn how NaturalVue® Enhanced Multifocal 1 Day Contact Lenses provide young athletes with reliable vision correction:https://t.co/Y2uhiEYMid MKT-VTI-SM54 r4.1
With summer here, parents will be scheduling eye exams for their children ahead of the school year. Set your patients up for academic and extracurricular success with NaturalVue® Enhanced Multifocal 1 Day Contact Lenses. Learn more: https://t.co/Y2uhiEYMid
MKT-VTI-SM54 r4.1
The majority (58%) of children wearing NaturalVue® Multifocal Contact Lenses had similar physiological growth as age-matched emmetropic children. Learn more: https://t.co/vQlH5EOKef
#PROTECT#VTI
Note: This reflects the 1-year data set.
VTI-RCT-SM9
Dr. David L. Kading recently wrote an article sharing his positive experience with NaturalVue® Enhanced Multifocal 1 Day™ Contact Lenses, calling it “an outstanding tool in our myopia management tool chest.”
Read the full article: https://t.co/f6anlSy3oh
#VTI
MKT-VTI-SM54 r3
May marks Healthy Vision Month!
This month talk to your patients about the importance of taking preventative steps to slow the progression of myopia and maintain healthy vision.
#HealthyVisionMonth#Myopia#VTI
MKT-VTI-SM54 r3
This Myopia Awareness Week, educate your patients and their parents about the serious risks of myopia and treatment options available to slow myopia progression.
Visit https://t.co/FOLL30UFyK myopia resources for your practice and patients.
#MAW2024
MKT-VTI-SM54 r3
Breaking news: VTI releases new data from PROTECT!
On May 6th, VTI presented new data from its 1-year RCT data set at ARVO in Seattle, Washington. Learn more in our latest announcement: https://t.co/E3LX3iF1Qy
#PROTECT#Myopia#VTI
VTI-RCT-SM9
ARVO 2024 Update From Myopia Profile:
#ARVO2024 Update 17: A Randomized Controlled Trial for Myopia Progression Control Using Catenary Power Profile Contact Lenses: 12-month Effectiveness and Safety. Abstract link: https://t.co/n2P4E0EIPC
...